HLA-C and Hodgkins lymphoma: A reduced MHC Class I and/or Class II antigen expression and a reduced antigenic peptide/MHC complex presentation (Figure 2), which often correlates with worse prognosis, is reportedly common in HL, affecting from 40% to 70% of cases (Diepstra et al., 2007; Reichel et al., 2015).